JAMES SAPIRSTEIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES SAPIRSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES SAPIRSTEIN. JAMES SAPIRSTEIN is Director in RespireRx Pharmaceuticals Inc. ($RSPI) and Chief Executive Officer in Alliqua BioMedical, Inc. ($ALQA) and Interim CEO in MARIZYME INC ($MARZ) and Director in Enochian Biosciences Inc ($DDRT) and Director in Probility Media Corp ($PBYA) and Chief Executive Officer in ContraVir Pharmaceuticals, Inc. ($CTRV) and PRESIDENT AND CEO in AzurRx BioPharma, Inc. ($AZRX).
Latest Insider Trading Transactions of JAMES SAPIRSTEIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALQA, AZRX, ENOB, HEPA, MARZ, PBYA, RSPI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | MARZ | MARIZYME INC | SAPIRSTEIN JAMES | Interim CEO | Option Exercise | A | 1.25 | 125,000 | 156,250 | 1,350,000 | |
| Mar 11 2021 | ENOB | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 3.77 | 19,894 | 75,000 | 19,894 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 64,935 | 55,195 | 64,935 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.77 | 13 | 10 | 13 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 1,200,000 | 1,020,000 | 1,200,000 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 64,935 | 55,195 | 64,935 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.77 | 13 | 10 | 13 | |
| Jul 20 2020 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.85 | 1,200,000 | 1,020,000 | 1,200,000 | |
| Oct 10 2019 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Option Exercise | A | 0.52 | 300,000 | 156,000 | 300,000 | |
| Oct 10 2019 | AZRX | AzurRx BioPharma, ... | SAPIRSTEIN JAMES | PRESIDENT AND CEO | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 6.25 | 9,173 | 57,331 | 9,173 | |
| Sep 27 2018 | DDRT | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 5.74 | 5,226 | 29,997 | 12,770 | |
| Jan 05 2018 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Grant | A | 0.00 | 322,092 | 0 | 492,819 | 170.7 K to 492.8 K (+188.66 %) |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | J | 1.45 | 38,114 | 55,265 | 38,114 | |
| Jul 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Grant | A | 0.00 | 141,061 | 0 | 170,727 | 29.7 K to 170.7 K (+475.50 %) |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Mar 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 1.48 | 313,898 | 464,569 | 2,761,129 | |
| Mar 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 1.43 | 313,898 | 448,874 | 2,447,231 | |
| Feb 15 2017 | PBYA | Probility Media Co ... | SAPIRSTEIN JAMES | Director | Grant | A | 0.79 | 75,000 | 59,250 | 210,000 | 135 K to 210 K (+55.56 %) |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 3.90 | 25,000 | 97,500 | 25,000 | |
| Oct 31 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | M | 1.50 | 16,666 | 24,999 | 2,133,334 | |
| Oct 31 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | M | 1.50 | 16,666 | 24,999 | 29,666 | 13 K to 29.7 K (+128.20 %) |
| Jun 14 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 0.99 | 500,000 | 495,000 | 2,150,000 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.02 | 10,000,000 | 227,000 | 10,000,000 | |
| Feb 18 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 1.00 | 10,000 | 10,000 | 13,000 | 3 K to 13 K (+333.33 %) |
| Dec 01 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 2.15 | 500 | 1,075 | 3,000 | 2.5 K to 3 K (+20.00 %) |
| Nov 24 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 1.64 | 2,500 | 4,100 | 2,500 | 0 to 2.5 K |
| Aug 20 2015 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.02 | 3,000,000 | 59,100 | 3,000,000 | |
| Jul 06 2015 | RSPI | RespireRx Pharmace ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 0.03 | 2,000,000 | 50,000 | 2,000,000 | |
| Jun 08 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 3.60 | 150,000 | 540,000 | 1,650,000 | |
| Nov 09 2012 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 0.00 | 3,095,469 | 0 | 3,095,469 | |
| Nov 09 2012 | ALQA | Alliqua BioMedical ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 0.10 | 9,286,408 | 928,641 | 9,286,408 |
Page: 1